M
Majid Eslami
Researcher at Semnan University
Publications - 74
Citations - 1451
Majid Eslami is an academic researcher from Semnan University. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 17, co-authored 57 publications receiving 805 citations. Previous affiliations of Majid Eslami include Tarbiat Modares University.
Papers
More filters
Journal ArticleDOI
Importance of probiotics in the prevention and treatment of colorectal cancer.
Majid Eslami,Bahman Yousefi,Parviz Kokhaei,Parviz Kokhaei,Maral Hemati,Zahra Rasouli Nejad,Vahid Arabkari,Afshin Namdar +7 more
TL;DR: Research in clinical trials encouraging findings that support a role of probiotics in CRC prevention and improve the safety and effectiveness of cancer therapy even though additional clinical research is still necessary.
Journal ArticleDOI
Sensing properties of BN nanotube toward carcinogenic 4-chloroaniline: A computational study
TL;DR: In this article, the viability of using a BN nanotube for detection of a para-chloroaniline molecule was studied by means of density functional theory calculations, and it was shown that the Si-doped tube not only can adsorb the molecule strongly, but also may detect its presence because of the drastic increase of the electrical conductivity of the tube.
Journal ArticleDOI
Probiotics importance and their immunomodulatory properties
Bahman Yousefi,Majid Eslami,Abdolmajid Ghasemian,Parviz Kokhaei,Parviz Kokhaei,Amir Salek Farrokhi,Narges Darabi +6 more
TL;DR: Some effects of modulation by probiotics include cytokine production by epithelial cells, increased mucin secretion, increased activity of phagocytosis, and activation of T and natural killer T cells, stimulation of immunoglobulin A production and decreased T cell proliferation.
Journal ArticleDOI
DNA nucleobase interaction with graphene like BC3 nano-sheet based on density functional theory calculations
Majid Eslami,Ali Ahmadi Peyghan +1 more
TL;DR: In this paper, the interaction of various nucleobases (guanine (G), adenine (A), thymine (T) and cytosine (C)) with a graphene-like BC 3 nanosheet using dispersion corrected B3LYP level of theory was reported.
Journal ArticleDOI
A global treatments for coronaviruses including COVID-19.
TL;DR: A therapeutic window of drugs available to patients with coronavirus disease‐19 is reached and an ACE2 inhibitor and a clinical problem reducing agent such as favipiravir in addition to hydroxychloroquine and corticosteroids are reached.